Xenon Pharmaceuticals to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
07 June 2023 - 6:35AM
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused
biopharmaceutical company, today announced that the company will
present at the Goldman Sachs 44th Annual Global Healthcare
Conference in Dana Point, CA.
Company Fireside Chat Presentation Details: |
|
|
Date: |
Monday, June 12, 2023 |
|
|
Time: |
10:00 am Pacific Time (1:00 pm Eastern Time) |
|
|
Webcast: |
Register here |
|
|
Presenters: |
Ian Mortimer, President and CEOSherry Aulin, CFO |
|
|
A live webcast of the company presentation will
be available on the “Investors” section of Xenon's website and
posted for replay following the event. The above listed dates and
times are subject to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (NASDAQ:XENE) is a
clinical stage biopharmaceutical company committed to developing
innovative therapeutics to improve the lives of patients with
neurological disorders. We are advancing a novel product pipeline
of neurology therapies to address areas of high unmet medical need,
with a focus on epilepsy. For more information, please visit
www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered
trademarks or trademarks of Xenon Pharmaceuticals Inc. in various
jurisdictions. All other trademarks belong to their respective
owner.
Investor/Media Contact:Jodi RegtsXenon
Pharmaceuticals Inc.Phone: 604.484.3353Email:
investors@xenon-pharma.com
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Apr 2023 to Apr 2024